
Celling Technologies provides autologous adult stem cell therapies to the clinician at the point of care. Our process promotes the regeneration of tissues by delivering a highly concentrated amount of the patient’s own stem cells. The stem cells are harvested from different tissues in the body and are concentrated and implanted.
We believe that regenerative medicine will forever redefine the landscape of medicine and elevate the standard of care in the global healthcare marketplace.